author-photo

Eva Dokoupilova

University of Veterinary and Pharmaceutical Sciences Brno

44

Papers

1611

Citations

Citation Trend

Filter By

Papers (28) Sort By

Journal Conference Others

P171 Efficacy and safety of upadacitinib in patients with active PsA and inadequate response to biologic DMARDs (SELECT-PsA-2): a double-blind, randomised controlled Phase III trial

2021 Rheumatology
Show All
- Source
- Cite
- Save
Citations (0)
POS0196 UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: 56-WEEK DATA FROM THE PHASE 3 SELECT-PSA 2 STUDY

2021 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Clinical effectiveness and safety of intra-articular injection of HYALGO in the management of knee osteoarthritis symptoms: A multicenter prospective study

2021 Journal of clinical orthopaedics and trauma
Show All
- Source
- Cite
- Save
Citations (0)
Secukinumab 150/300 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 3‐Year Results from the Phase 3 MEASURE 3 Study

2020
Show All
- Source
- Cite
- Save
Citations (11)
OP0106 SECUKINUMAB 150 MG SIGNIFICANTLY IMPROVED SIGNS AND SYMPTOMS OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM THE PHASE III PREVENT STUDY

2020 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (4)
Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2

2020 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (33)
OP0223 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PSA-2): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL

2020 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (13)
An international, multicentre, double-blind, randomized study (DISSCO): effect of diacerein vs celecoxib on symptoms in knee osteoarthritis.

2020 Rheumatology
Show All
- Source
- Cite
- Save
Citations (6)
Dose-response of hyaluronate-based viscoelastic hydrogels for the treatment of knee osteoarthrosis: a prospective, randomized, comparative clinical trial

2020 Minerva Ortopedica E Traumatologica
Show All
- Source
- Cite
- Save
Citations (1)
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

2019 The Lancet Diabetes & Endocrinology
Show All
- Source
- Cite
- Save
Citations (54)